Oral Session 2-13C MDS：Basic (2)

[OS2-13C-5] PPM1D mutations in healthy individuals and myeloid neoplasms

Masanori Motomura¹, Yoshikage Inoue¹, Yasunobu Nagata¹, Tetsuichi Yoshizato¹, Constance Baer², Yukihide Momozawa³, Niroshan Nadarajah², Tamara Alpermann², Yasuhito Nanya¹, Kenichi Yoshida¹, Claudia Haferlach², Wolfgang Kern², Yoshiko Atsuta^4,5, Yuka Iijima⁶, Yuichi Shiraishi⁷, Makoto Onizuka⁸, Kenichi Chiba⁷, Hiroko Tanaka⁷, Hidehiro Itonaga⁹, Yasushi Miyazaki⁹, Keizo Horibe⁶, Masashi Sanada^1,6, Yoichiro Kamatani³, Michiaki Kubo³, Satoru Miyano⁷, Torsten Haferlach², Hideki Makishima¹, Seishi Ogawa^1,10 (1.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 2.MLL Munich Leukemia Laboratory, Munich, Germany, 3.Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan, 4.Department of Healthcare Administration, Nagoya University, Nagoya, Japan, 5.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 6.National Hospital Organization Nagoya Medical Center, Nagoya, Japan, 7.Human Genome Center, Tokyo University, Tokyo, Japan, 8.Department of Hematology and Oncology, Tokai University, Isehara, Japan, 9.Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan, 10.Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden)